S. Sherratt

发表

EPA and DHA containing phospholipids have contrasting effects on membrane structure

Deepak L. Bhatt, P. Libby, R. Mason, 2021, Journal of lipid research.

A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes.

P. Libby, R. Mason, S. Sherratt, 2022, Prostaglandins, leukotrienes, and essential fatty acids.

Progressive LDL Reduction to Very Low Levels Improves Dimeric Nitric Oxide Synthase, Nitric Oxide Bioavailability and Reduces Peroxynitrite in Endothelial Cells during Hyperglycemia

T. Malinski, R. Mason, S. Sherratt, 2019, American Journal of Pharmacology and Toxicology.

Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction.

R. Mason, S. Sherratt, 2018, Chemistry and physics of lipids.

Omega-3-fatty acids: Do they prevent cardiovascular disease?

R. Eckel, R. Mason, S. Sherratt, 2022, Best practice & research. Clinical endocrinology & metabolism.

Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability.

Deepak L. Bhatt, T. Malinski, R. Mason, 2021, Prostaglandins, leukotrienes, and essential fatty acids.

Rationale for different formulations of omega-3 fatty acids leading to differences in residual cardiovascular risk reduction.

R. Eckel, S. Sherratt, P. Mason, 2022, Metabolism: clinical and experimental.

Multi-scale analysis of habitat fragmentation on small-mammal abundance and tick-borne pathogen infection prevalence in Essex County, MA

J. Topp, M. Muthersbaugh, S. Sherratt, 2022, PloS one.

Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits.

R. Mason, S. Sherratt, R. Preston Mason, 2017, Biochemical and biophysical research communications.

The nonlinear effect of alkyl chain length in the membrane interactions of phenolipids: Evidence by X‐ray diffraction analysis

P. Villeneuve, Erwann Durand, J. Lecomte, 2017 .

Polyphenol Alkyl Ester Inhibits Membrane Cholesterol Domain Formation Through an Antioxidant Mechanism Based, in Nonlinear Fashion, on Chain Length

P. Villeneuve, Erwann Durand, R. Jacob, 2017 .

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes.

S. Shrivastava, A. Chattopadhyay, R. Jacob, 2016, Biochimica et biophysica acta.

Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence

R. Mason, S. Sherratt, Michael W. Lero, 2020, Current opinion in lipidology.

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

P. Libby, M. Budoff, R. Mason, 2022, Current Atherosclerosis Reports.

Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin.

T. Malinski, R. Jacob, R. Mason, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents

R. Jacob, R. Mason, S. Sherratt, 2016, Journal of cardiovascular pharmacology.

Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution.

P. Libby, R. Mason, S. Sherratt, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro.

R. Mason, R. Juliano, S. Sherratt, 2020, Biochimica et biophysica acta. Biomembranes.

Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid.

R. Mason, S. Sherratt, 2018, Biochemical and biophysical research communications.

Kinetics of generic tacrolimus in heart transplantation: A cautionary note.

R. Starling, M. Mehra, R. Mason, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Rosmarinic acid and its esters inhibit membrane cholesterol domain formation through an antioxidant mechanism based, in nonlinear fashion, on alkyl chain length.

P. Villeneuve, Erwann Durand, R. Mason, 2019, Biochimica et biophysica acta. Biomembranes.

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes.

S. Shrivastava, A. Chattopadhyay, R. Jacob, 2016, Biochimica et biophysica acta.

Do patients benefit from omega-3 fatty acids?

S. Sherratt, Peter Libby, Deepak L. Bhatt, 2023, Cardiovascular research.

Abstract 16934: Eicosapentaenoic Acid Inhibits Lipoprotein(a) With Higher Rates of Oxidation Compared to Non-Modified Low-Density Lipoprotein in vitro

S. Sherratt, P. Mason, D. Bhatt, 2023, Circulation.

Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model

P. Libby, R. Mason, S. Sherratt, 2023, Journal of the American Heart Association.

Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation

S. Sherratt, H. Dawoud, Peter Libby, 2024, Journal of the American Heart Association.